Blood Pressure Reduction Induced By Low Dose Of Epinephrine Via Different Routes In Rats

Jing Wu,Mu-Huo Ji,Zhong-Yun Wang,Wei Zhu,Jian-Jun Yang,Yong G. Peng
DOI: https://doi.org/10.1097/FJC.0b013e3182a1e118
IF: 3.271
2013-01-01
Journal of Cardiovascular Pharmacology
Abstract:Background:Epinephrine was recently shown to induce a hypotension episode. Activation of (2)-adrenoceptors with smooth muscle relaxation may be the underlying mechanism. This study investigated the effects of ICI 118551, a (2)-adrenoceptors antagonist, on epinephrine-induced blood pressure reduction via different administration routes in rats.Methods:A total of 144 Sprague Dawley rats were equally randomized into 3 groups (intranasal, intravenous, and intra-arterial administration), each with 4 subgroups: saline + saline, ICI 118551 + saline, saline + epinephrine, and ICI 118551 + epinephrine. All rats were anesthetized while spontaneously breathing. Epinephrine was administered at doses of 5 g/kg via nose, 0.25 g/kg via femoral vein, and 0.1 g/kg via aorta. Mean arterial pressure and heart rate were monitored.Results:Mean arterial pressure decreased in all 3 saline + epinephrine subgroups after administration (P < 0.05), whereas it did not in other subgroups. Heart rate had no significant change in all subgroups.Conclusions:Epinephrine-induced blood pressure reduction can be prevented by ICI 118551 in rats, suggesting that the activation of (2)-adrenoceptors contributes to blood pressure reduction.
What problem does this paper attempt to address?